Akshay Gupta, MD
Gastroenterology · Meridian, IDNPI 1255542338
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Si-bone, Inc. at 36.4% of the total. Reporting peaked in 2021 at $637 and has fallen 70.0% since, to $191 in 2025. That places this record below the midpoint for gastroenterology clinicians in ID, where the typical reported total is $1,538.
Across 53 payments — averaging $30.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Si-bone, Inc.$591
- AbbVie$415
- Takeda Pharmaceuticals U.S.A., Inc.$127
- Johnson & Johnson$117
- Lilly USA, LLC$55
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$43
- plus $276 from 12 others
What the payments were for
- Travel & lodging$56535%
- Food & beverage$96760%
- Education$906%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Si-bone, Inc. | 2 | $591 |
| AbbVie | 21 | $415 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $127 |
| Johnson & Johnson | 3 | $117 |
| Lilly USA, LLC | 3 | $55 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $43 |
| Bristol Myers Squibb | 2 | $37 |
| Fresenius Kabi USA, LLC | 1 | $34 |
| Braintree Laboratories, Inc. | 2 | $32 |
| Pfizer | 2 | $31 |
| Sanofi | 1 | $29 |
| Boehringer Ingelheim | 1 | $27 |
| Intercept Pharmaceuticals, Inc. | 2 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Alfasigma USA, Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
| Merck | 1 | $12 |
| Itamar Medical Inc | 1 | $2 |
How this compares
$1,622 in reported general payments places this provider in the 50th percentile of 70 gastroenterology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 15 | $141,350 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 272 | $17,405 |
| Omeprazole | 312 | $6,302 |
| Mesalamine | 12 | $4,183 |
| Budesonide DrBudesonide | 37 | $2,289 |
| Ursodiol | 16 | $1,762 |
| Ondansetron OdtOndansetron | 341 | $1,752 |
| CholestyramineCholestyramine (With Sugar) | 13 | $1,228 |
| Sucralfate | 55 | $1,056 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 38 | $686 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 42 | $665 |
| Pantoprazole Sodium | 28 | $526 |
| Famotidine | 20 | $385 |
| Esomeprazole Magnesium | 12 | $360 |
| LoperamideLoperamide Hcl | 12 | $198 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Meridian
- Bruce CroffyMeridian$4K
- Brian StoryMeridian$2K
- Mark Dell'aglioMeridian$550
- John DeverMeridian$414
- David JohnsonCoeur D Alene$190K
- Matthew SericatiBoise$111K
- Ashley EvansBoise$69K
- Bryan BrimhallBoise$10K
- Todd WilliamsIdaho Falls$8K
- Caleb KellyCoeur D Alene$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.